Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Expert Opinion on Emerging Drugs|September 4, 2008
Emerging drugs for schizophreniaOfer Agid, Shitij Kapur, Gary Remington
CNS Drugs|December 25, 2009
Progress in defining optimal treatment outcome in schizophreniaGary Remington, George Foussias, Ofer Agid
Schizophrenia Research|May 19, 2015
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcomeGagan Fervaha, George Foussias, Ofer Agid, et al.
Neuroscience and Biobehavioral Reviews|September 17, 2013
Neural substrates underlying effort computation in schizophreniaGagan Fervaha, George Foussias, Ofer Agid, et al.
Schizophrenia Research. Cognition|July 14, 2021
Cognitive discrepancies, motivation and subjective well-being in people with schizophreniaDaniel Krzyzanowski, Ofer Agid, Vina Goghari, et al.
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2006
How antipsychotics work-from receptors to realityShitij Kapur, Ofer Agid, Romina Mizrahi, et al.
Schizophrenia Research|August 29, 2017
Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysisHiroyoshi Takeuchi, Sadhana Thiyanavadivel, Ofer Agid, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 23, 2010
Where to position clozapine: re-examining the evidenceOfer Agid, George Foussias, Shayna Singh, et al.
Psychiatry Research|August 6, 2013
Amotivation and functional outcomes in early schizophreniaGagan Fervaha, George Foussias, Ofer Agid, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 27, 2013
Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disordersGeorge Foussias, Ofer Agid, Gagan Fervaha, et al.
Pageof 13